Centessa Pharmaceuticals (CNTA) Other financing activities (2021 - 2025)

Centessa Pharmaceuticals (CNTA) reported Other financing activities of -$5000.0 for Q4 2025, up 98.74% quarter-over-quarter from -$396000.0 in Q1 2025.

Centessa Pharmaceuticals (CNTA) Other financing activities (2021 - 2025) Analysis & Trends

Centessa Pharmaceuticals (CNTA) has 3 years of Other financing activities data on file, last reported at -$5000.0 in Q4 2025.

  • Other financing activities for Q4 2025 came in at -$5000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$5000.0 (up 98.74% YoY), and the FY2025 annual result was -$401000.0, changed N/A from the prior year.
  • Other financing activities advanced to -$5000.0 in Q4 2025 per CNTA's latest filing, from -$396000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $12000.0 in Q4 2021 and troughed at -$396000.0 in Q1 2025.
  • A 3-year average of -$191400.0 and a median of -$261000.0 in 2022 frame the typical range for Other financing activities.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Centessa Pharmaceuticals 6.15 Bn 6.15 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -5,000.00
Dec 31, 2025 -5,000.00
Mar 31, 2025 -396,000.00
Mar 31, 2025 -396,000.00
Mar 31, 2022 -261,000.00
Mar 31, 2022 -261,000.00
Dec 31, 2021 12,000.00
Dec 31, 2021 12,000.00
Sep 30, 2021 -307,000.00
Sep 30, 2021 -307,000.00